Medical Imaging, Parkinson's / 12.02.2026

[caption id="attachment_72368" align="aligncenter" width="500"]parkinson's-hand-image-tremors.jpg Freepix[/caption]

The unmet need of Parkinson’s disease

Parkinson's disease (PD) is a progressive neurodegenerative disease of the central nervous system (CNS). The condition causes neurons in parts of the brain to become weak, damaged, and die, leading to symptoms of muscle stiffness, resting tremors, impaired balance, and problems with movement and expression. In addition to the obvious physical symptoms, people suffering from Parkinson’s disease often face mental and emotional health problems, difficulty swallowing and chewing, changes to their speech, skin, and sleep, as well as pain and fatigue, muscle cramps, and a whole range of potential cognitive and psychiatric issues. According to the World Health Organization, Parkinson’s disease is the world’s fastest growing neurological disorder, with prevalence having doubled in the last 25 years, accounting for almost 8.5 million cases globally. Current treatment options focus on symptom management, including dopaminergic therapies and enzyme inhibitors, with no cure and no currently available treatments to stop disease progression. Parkinson’s disease, therefore, remains a significant research priority, with the focus currently placed on finding treatments that can effectively slow disease progression, while continuing to enhance existing symptomatic treatments. Research in this area is complex, given the heterogeneity of symptoms, gradual neurodegeneration, and subtle early disease changes, the combination of which makes clinical trial imaging particularly challenging. This article will consider the current landscape of PD-specific imaging modalities and their applications, as well as highlighting the role of an experienced imaging clinical research organization (CRO) in CNS clinical trials management.
Medical Imaging / 29.07.2025

[caption id="attachment_70070" align="aligncenter" width="500"]expert-medical-imaging-review Photo by Towfiqu barbhuiya[/caption] When it comes to clinical trials, the accuracy and reliability of data are paramount. Among the many types of data collected, imaging data plays a crucial role, particularly in fields such as oncology, cardiology, and neurology. However, managing and interpreting this data can be complex, and errors or inconsistencies can significantly impact trial outcomes. This is where expert image review and analysis come into play, offering a pathway to enhanced accuracy, consistency, and ultimately, improved trial outcomes. The Role of Imaging in Clinical Trials Imaging techniques such as MRI, CT scans, and PET scans provide critical insights into disease progression, treatment efficacy, and patient responses. These images help researchers visualize changes within the body that might not be evident through other data forms. However, the sheer volume and complexity of imaging data in clinical trials present challenges, including variability in image quality, differences in acquisition protocols, and subjective interpretation by different readers. Why Expert Image Review Matters Expert image review refers to the process where trained radiologists or imaging specialists carefully examine trial images to ensure they meet the highest standards of quality and consistency. This step helps to:
  • Reduce Variability: Different sites and operators might acquire images differently. Expert reviewers ensure that images are standardized and comparable across sites.
  • Improve Accuracy: Trained specialists are more adept at identifying subtle changes or abnormalities, reducing the risk of false positives or negatives.
  • Ensure Compliance: Adhering to trial protocols and regulatory requirements is critical. Expert reviewers help maintain protocol compliance in image acquisition and analysis.
These factors combine to produce more reliable data, which translates into stronger evidence when evaluating a treatment’s efficacy or safety.
CT Scanning, Medical Imaging, MRI, Radiology / 02.06.2025

[caption id="attachment_68888" align="aligncenter" width="500"]ct-vs-mri-what-are-the-differences Photo by MART PRODUCTION[/caption] Imagine two powerful, non-invasive imaging tools, each with its own unique set of capabilities. Both MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) scans are essential in the medical field for diagnosing and treating a wide range of conditions. Yet, they operate on entirely different principles and are used in distinct scenarios. Understanding the differences between MRI and CT scans can empower patients to make informed decisions about their healthcare. This article will delve into the workings of MRI and CT scans, their benefits and drawbacks, and why a healthcare professional might choose one over the other.

How MRI and CT Scans Work

MRI St George uses a strong magnetic field and radio waves to create detailed images of the body's soft tissues, including the brain, spine, joints, and organs. The magnetic field aligns the water molecules in your body, and as they return to their natural state, they emit energy that is detected and converted into detailed images by a computer. MRI is excellent at visualizing internal structures and can differentiate between various types of tissue. On the other hand, CT scans rely on X-rays to produce cross-sectional images of the body. The X-ray beam moves around the patient, capturing images from multiple angles. These images are then reconstructed by a computer into a detailed, 3D picture of the internal body structures. CT scans are particularly adept at capturing images of bones, blood vessels, and organs.
Medical Imaging, Technology / 27.06.2024

Endoscopy, a crucial diagnostic and therapeutic tool in modern medicine, is constantly evolving. Advancements in technology are set to revolutionise how endoscopic procedures are performed, enhancing their accuracy, safety, and efficacy. Here, we explore the emerging trends and innovations shaping the future of endoscopy.

Artificial Intelligence and Machine Learning

One of the most promising developments in endoscopy is the integration of artificial intelligence (AI) and machine learning. These technologies enhance diagnostic capabilities by providing real-time image analysis, which helps in the identification of abnormalities, polyps, and early signs of cancer with unprecedented accuracy. Machine learning algorithms can also predict patient outcomes and suggest personalised treatment plans based on vast amounts of historical data, improving overall patient care.

Miniaturisation and Micro-Robotics

The trend towards miniaturisation is leading to the development of swallowable capsules equipped with tiny cameras. These capsules can capture high-quality images of the gastrointestinal tract as they travel through it, offering a less invasive alternative to traditional endoscopy. Additionally, micro-robotic devices are being developed to navigate and perform procedures within the body with high precision, reducing the need for larger incisions and enhancing recovery times.